Wanrudee Isaranuwatchai


Director, Centre for Excellence in Economic Analysis Research


Dr. Wanrudee Isaranuwatchai is a Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital.

She is an Interim Director and a Health Economist at the Centre for Excellence in Economic Analysis Research (CLEAR), a part of the HUB Health Research Solutions at St. Michael’s Hospital. She is also an Assistant Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto.

Dr. Isaranuwatchai has collaborated with researchers and decision-makers in various topics areas to help communicate the value of health programs/initiatives using economic evidence. She has experience conducting economic evaluations using person-level data and decision modeling. Dr. Isaranuwatchai’s research focuses on applied economic evaluation (e.g., how to make economic evaluation more useful to researchers, health providers, and decision-makers) and health economics methods.

Recent Publications

  1. Magnus, A, Isaranuwatchai, W, Mihalopoulos, C, Brown, V, Carter, R. A Systematic Review and Meta-Analysis of Prostate Cancer Utility Values of Patients and Partners Between 2007 and 2016. MDM Policy Pract. ;4 (1):2381468319852332. doi: 10.1177/2381468319852332. PubMed PMID:31192309 PubMed Central PMC6540514.
  2. Hoch, JS, Hay, A, Isaranuwatchai, W, Thavorn, K, Leighl, NB, Tu, D et al.. Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial. BMC Cancer. 2019;19 (1):552. doi: 10.1186/s12885-019-5779-x. PubMed PMID:31174497 PubMed Central PMC6555934.
  3. Tangjitgamol, S, Tharavichitkul, E, Tovanabutra, C, Rongsriyam, K, Asakij, T, Paengchit, K et al.. A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial. J Gynecol Oncol. 2019;30 (4):e82. doi: 10.3802/jgo.2019.30.e82. PubMed PMID:31074236 PubMed Central PMC6543099.
  4. Isaranuwatchai, W, Li, R, Glassman, A, Teerawattananon, Y, Culye, AJ, Chalkidou, K et al.. Disease Control Priorities Third Edition: Time to Put a Theory of Change Into Practice Comment on "Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy". Int J Health Policy Manag. 2018;8 (2):132-135. doi: 10.15171/ijhpm.2018.115. PubMed PMID:30980627 PubMed Central PMC6462203.
  5. Mighton, C, Carlsson, L, Clausen, M, Casalino, S, Shickh, S, McCuaig, L et al.. Development of patient "profiles" to tailor counseling for incidental genomic sequencing results. Eur. J. Hum. Genet. 2019; :. doi: 10.1038/s41431-019-0352-2. PubMed PMID:30846854 .
  6. McGillion, MH, Henry, S, Busse, JW, Ouellette, C, Katz, J, Choinière, M et al.. Examination of psychological risk factors for chronic pain following cardiac surgery: protocol for a prospective observational study. BMJ Open. 2019;9 (2):e022995. doi: 10.1136/bmjopen-2018-022995. PubMed PMID:30826789 PubMed Central PMC6398732.
  7. John-Baptiste, AA, Li, L, Isaranuwatchai, W, Osuch, E, Anderson, KK. Healthcare utilization costs of emerging adults with mood and anxiety disorders in an early intervention treatment program compared to a matched cohort. Early Interv Psychiatry. 2019; :. doi: 10.1111/eip.12790. PubMed PMID:30688032 .
  8. Tanaree, A, Assanangkornchai, S, Isaranuwatchai, W, Thavorn, K, Coyte, PC. Integrated treatment program for alcohol related problems in community hospitals, Songkhla province of Thailand: A social return on investment analysis. PLoS ONE. 2019;14 (1):e0209210. doi: 10.1371/journal.pone.0209210. PubMed PMID:30601850 PubMed Central PMC6314591.
  9. Tan, MG, Isaranuwatchai, W, DeLyzer, T, Butler, K, Hofer, SOP, O'Neill, AC et al.. A cost-effectiveness analysis of DIEP vs free MS-TRAM flap for microsurgical breast reconstruction. J Surg Oncol. 2019;119 (3):388-396. doi: 10.1002/jso.25325. PubMed PMID:30562406 .
  10. Stevenson, JKR, Qiao, Y, Chan, KKW, Beca, J, Isaranuwatchai, W, Guo, H et al.. Improved survival in overweight and obese patients with aggressive B-cell lymphoma treated with rituximab-containing chemotherapy for curative intent. Leuk. Lymphoma. 2019;60 (6):1399-1408. doi: 10.1080/10428194.2018.1538509. PubMed PMID:30516081 .
Search PubMed

Affiliations & Other Activities

  • Scientist, Li Ka Shing Institute
  • Assistant Professor, Institute for Health Policy, Management and Evaluation, University of Toronto